200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 82626-01-5

82626-01-5

82626-01-5 | Alpidem

CAS No: 82626-01-5 Catalog No: AG005CEI MDL No:

Product Description

Catalog Number:
AG005CEI
Chemical Name:
Alpidem
CAS Number:
82626-01-5
Molecular Formula:
C21H23Cl2N3O
Molecular Weight:
404.3328
IUPAC Name:
2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide
InChI:
InChI=1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3
InChI Key:
JRTIDHTUMYMPRU-UHFFFAOYSA-N
SMILES:
CCCN(C(=O)Cc1c(nc2n1cc(Cl)cc2)c1ccc(cc1)Cl)CCC
UNII:
I93SC245QZ

Properties

Complexity:
478  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
403.122g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
404.335g/mol
Monoisotopic Mass:
403.122g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
37.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.8  

Literature

Title Journal
Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates? Journal of applied toxicology : JAT 20150901
A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. Toxicological sciences : an official journal of the Society of Toxicology 20140101
Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicological sciences : an official journal of the Society of Toxicology 20131201
Anxioselective anxiolytics: on a quest for the Holy Grail. Trends in pharmacological sciences 20121101
Palmitate increases the susceptibility of cells to drug-induced toxicity: an in vitro method to identify drugs with potential contraindications in patients with metabolic disease. Toxicological sciences : an official journal of the Society of Toxicology 20121001
Synthesis of imidazopyridines from the Morita-Baylis-Hillman acetates of nitroalkenes and convenient access to Alpidem and Zolpidem. Organic letters 20120907
Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator protein. Journal of medicinal chemistry 20120510
Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20120401
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold. Journal of medicinal chemistry 20111027
In vitro metabolism of tiletamine, zolazepam and nonbenzodiazepine sedatives: Identification of target metabolites for equine doping control. Drug testing and analysis 20111001
Ethyl 8-amino-6-bromoimidazo[1,2-a]pyridine-2-carb-oxy-late. Acta crystallographica. Section E, Structure reports online 20110601
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals 20101201
Ethyl 8-(4-nitro-phen-yl)imidazo[1,2-a]pyridine-7-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20101201
General and efficient copper-catalyzed three-component coupling reaction towards imidazoheterocycles: one-pot synthesis of alpidem and zolpidem. Angewandte Chemie (International ed. in English) 20100401
Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins. Drug metabolism and disposition: the biological fate of chemicals 20091201
6-Benzyl-3,4-dimeth-oxy-10-methyl-pyrido[2',1':2,3]imidazo[4,5-c]isoquinolin-5(6H)-one. Acta crystallographica. Section E, Structure reports online 20091001
Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation. Oxidative medicine and cellular longevity 20090101
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis. Journal of medicinal chemistry 20080925
Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem. Bioorganic & medicinal chemistry 20080315
New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluation. Journal of medicinal chemistry 20070125
Effects of calcium channel blockers on antidepressant action of Alprazolam and Imipramine. The Libyan journal of medicine 20070101
N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor. Journal of medicinal chemistry 20040325
Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands. Bioorganic & medicinal chemistry 20040115
Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124]. BMC clinical pharmacology 20040101
Alpidem analogues containing a GABA or glycine moiety as new anticonvulsant agents. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20030301
SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. The Journal of pharmacology and experimental therapeutics 20020601
GABAA-benzodiazepine receptor complex ligands and stress-induced hyperthermia in singly housed mice. Pharmacology, biochemistry, and behavior 20020501
[Hepatic tolerance of atypical antipsychotic drugs]. L'Encephale 20020101
Toxicity of alpidem, a peripheral benzodiazepine receptor ligand, but not zolpidem, in rat hepatocytes: role of mitochondrial permeability transition and metabolic activation. The Journal of pharmacology and experimental therapeutics 20011101
2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands. Bioorganic & medicinal chemistry 20011001
Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. Journal of hepatology 20010401
[3H]Ro 15-1788 binding sites to brain membrane of the saltwater Mugil cephalus. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20010301
A structure-activity relationship study of the affinity of selected imidazo[1,2-a]pyridine derivatives, congeners of zolpidem, for the omega 1-subtype of the benzodiazepine receptor. Acta poloniae pharmaceutica 20010101
[Subfulminant hepatitis caused by alpidem and treated by liver transplantation]. Gastroenterologie clinique et biologique 19950201
[Hepatitis induced by alpidem (Ananxyl). Four cases, one of them fatal]. Gastroenterologie clinique et biologique 19940101
[A new case of hepatitis after alpidem monotherapy]. Gastroenterologie clinique et biologique 19940101
Repeated treatment with alpidem, a new anxiolytic, does not induce tolerance or physical dependence. Neuropharmacology 19930901
Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers. Pharmacopsychiatry 19900501

© 2019 Angene International Limited. All rights Reserved.